Skip to main content

Protocol B

Type:
Incidence / prospective cohort
Study Status:
Ongoing
Enrollment Status:
Open
Countries:
Kenya;Uganda;South Africa
Partners:
Uganda Virus Research Institute-International AIDS Vaccine Initiative (UVRI-IAVI)-Entebbe, Uganda; Kenya AIDS Vaccine Initiative-Kangemi (KAVI-Kangemi), Nairobi, Kenya; Kenya Medical Research Institute-Centre for Geographic Medicine Research-Coast (KEMRI-CGMRC), Kilifi, Kenya; Medical Research Council (MRC-Entebbe)-Entebbe, Uganda; Medical Research Council (MRC-Masaka)-Masaka, Uganda; Desmond Tutu HIV Foundation (DTHF)-Masiphumele, Cape Town, South Africa; Aurum Institute, Rustenburg, South Africa.

Study Summary:
 
To estimate the annual incidence of HIV infection, characterize early HIV infection, and prepare clinical trial sites for HIV preventive vaccine efficacy trials for which volunteers from this study cohort may be recruited